Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma

Abroad (travel likely)Recruiting

Conditions

Esophageal Cancer · Recurrence · DNA Methylation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Nagoya University, Nagoya, Aichi-ken, Japan
Contact: Study coordinator (Fuminori Sonohara, PhD) · Fuminori.sonohara@bswhealth.org
Yamanashi Universiy, Chūō, Yamanashi, Japan
Contact: Study coordinator (Katsutoshi Shoda, PhD) · kshoda@yamanashi.ac.jp

Study leads

Koichi Takiguchi, PhD
Principal Investigator
City of Hope Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

Esophageal Cancer · Oesophageal Cancer · GastroEsophageal Cancer

Abroad (travel likely)RecruitingPHASE2

Milwaukee, United States

Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery

Colorectal Carcinoma · Rectal Prolapse · Prostate Cancer (Adenocarcinoma)

Abroad (travel likely)Recruiting

Hong Kong, China

18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer

Esophageal Cancer

Abroad (travel likely)RecruitingPHASE1

Houston, United States

Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC

Esophageal Cancer

Abroad (travel likely)RecruitingPHASE2

Tianjin, China